Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ABSI


Fundamental

Company: Absci Corp
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.85
Insider Own: 13.27%
Shs Outstand: 151.52M
Perf Week: -2.61%
Market Cap: 456.00M
Forward P/E: -
EPS next Y: -0.78
Insider Trans: 0.85%
Shs Float: 132.72M
Perf Month: 21.63%
Enterprise Value: 317.01M
PEG: -
EPS next Q: -0.19
Inst Own: 73.77%
Short Float: 28.13%
Perf Quarter: -13.37%
Income: -115.18M
P/S: 162.86
EPS this Y: 7.67%
Inst Trans: 19.75%
Short Ratio: 10.48
Perf Half Y: -28.71%
Sales: 2.80M
P/B: 2.38
EPS next Y Percentage: -0.25%
ROA: -53.59%
Short Interest: 37.33M
Perf YTD: -14.61%
Book/sh: 1.25
P/C: 3.16
EPS next 5Y: 30.25%
ROE: -62.50%
52W High: 5.23 -43.00%
Perf Year: 21.38%
Cash/sh: 0.94
P/FCF: -
EPS past 3/5Y: 9.99% -9.45%
ROIC: -59.97%
52W Low: 2.24 33.04%
Perf 3Y: 68.36%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -21.31% -10.14%
Gross Margin: -319.36%
Volatility W: 6.63%
Volatility M: 8.18%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 113.22
EPS Y/Y TTM: 9.35%
Oper. Margin: -4479.21%
ATR (14): 0.22
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 6.57
Sales Y/Y TTM: -38.24%
Profit Margin: -4113.68%
RSI (14): 53.95
Recom: 1.40
Dividend Gr. 3/5Y: - -
Current Ratio: 6.57
EPS Q/Q: 22.47%
SMA20: 2.56%
Beta: 1.98
Target Price: 8.03
Payout: -
Debt/Eq: 0.03
Sales Q/Q: -2.26%
SMA50: 7.52%
Rel Volume: 1.08
Prev Close: 2.95
Employees: 140
LT Debt/Eq: 0.01
Earnings: Mar 24 AMC
SMA200: -3.61%
Avg Volume: 3.56M
Price: 2.98
IPO: Jul 22, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: -12.49% -54.19%
Trades:
Volume: 3,849,598
Change: 1.02%

Technical:


Latest News:

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbSci (ABSI) and ... neutral
ABSI AMGN

Summary: Analysts weigh in on AbSci (ABSI) and Amgen (AMGN) in the Healthcare sector with price targets and ratings provided.

Full article
2024-05-20T15:43:14Z